BioRem Inc.
BRM.V · TSXV
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | CA$0 | CA$0 | CA$0 | CA$0 |
| - Cash | CA$0 | CA$0 | CA$0 | CA$0 |
| + Debt | CA$0 | CA$0 | CA$0 | CA$0 |
| Enterprise Value | CA$0 | CA$0 | CA$0 | CA$0 |
| Revenue | CA$0 | CA$0 | CA$0 | CA$0 |
| % Growth | 48.7% | -12.8% | 17.9% | – |
| Gross Profit | CA$0 | CA$0 | CA$0 | CA$0 |
| % Margin | 26.9% | 27.9% | 30.4% | 25.5% |
| EBITDA | CA$0 | CA$0 | CA$0 | CA$0 |
| % Margin | 12.9% | 13.7% | 10.4% | 10.9% |
| Net Income | CA$0 | CA$0 | CA$0 | CA$0 |
| % Margin | 8.1% | 8.7% | 5.6% | 5.3% |
| EPS Diluted | 0.16 | 0.13 | 0.092 | 0.035 |
| % Growth | 23.1% | 41.5% | 164.8% | – |
| Operating Cash Flow | CA$0 | CA$0 | CA$0 | CA$0 |
| Capital Expenditures | -CA$0 | -CA$0 | -CA$0 | -CA$0 |
| Free Cash Flow | CA$0 | -CA$0 | CA$0 | CA$0 |